June 01st, 2023

In a significant development, the United States and Guatemala have issued a joint statement on migration, outlining their collaborative efforts to tackle the pressing issue of irregular migration. Following a constructive conversation between Guatema. Read more

June 01st, 2023

Molecular Templates, Inc. (Nasdaq: MTEM), a biopharmaceutical company, received positive news from the U.S. Food and Drug Administration (FDA) regarding its MT-0169 trial.  The FDA has lifted the partial clinical hold on patient enrollment, all. Read more

June 01st, 2023

Dollar General Corporation (NYSE: DG), a leading discount retailer, reported first-quarter fiscal 2023 earnings per share (EPS) of $2.34, slightly below the consensus estimate of $2.38.  The company acknowledged a more challenging macroeconom. Read more

June 01st, 2023

Bilibili Inc. (Nasdaq: BILI), a Chinese online entertainment platform, had a promising start to the first quarter of 2023, showing significant improvement in gross profit and a notable reduction in losses. The company reported an adjusted loss of $0.. Read more

June 01st, 2023

Li Auto Inc. (Nasdaq: LI), a Chinese electric vehicle manufacturer, announced that it achieved a remarkable milestone in May 2023 by delivering 28,277 vehicles, representing a 146.0% year-over-year increase.  Xiang Li, Chairman and CEO of Li . Read more

June 01st, 2023

In a statement released yesterday, President Joe Biden expressed his appreciation for the House of Representatives' passage of the Bipartisan Budget Agreement, emphasizing its significance in averting a potential default and preserving the nation's h. Read more

June 01st, 2023

Cedar Fair, L.P. (NYSE: FUN), a leading operator of amusement parks and water parks, has been initiated with a Buy rating by Goldman Sachs, with a price target of $50.  $FUN closed at $44.62 on Wednesday, indicating a potential upside of $5.3. Read more

June 01st, 2023

Pfizer Inc. (NYSE: PFE), a global pharmaceutical company specializing in vaccines and medicines, announced that its bivalent RSV prefusion F (RSVpreF) vaccine, ABRYSVO, has received approval from the U.S. Food and Drug Administration (FDA).  . Read more

June 01st, 2023

Xylem Inc. (NYSE: XYL) has received an upgrade from Neutral to Outperform by Robert W. Baird, with the price target raised from $122 to $135.  On Wednesday, $XYL closed at $100.20, indicating a potential upside of $34.80 or 34.72% based on th. Read more

June 01st, 2023

HOOKIPA Pharma Inc. (Nasdaq: HOOK) has released promising preliminary data from its Phase 2 study of HB-200 in combination with pembrolizumab, offering hope for patients with recurrent/metastatic Human Papillomavirus 16-positive (HPV16+) head and nec. Read more